StockData
Traws Pharma, Inc. logo

Traws Pharma, Inc. (TRAW) income statement

TRAWNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/30
$0.17−0.06 (-23.91%)

Close on Nov 20, 2026Market cap $2.69MP/E –Yield –

See a number that looks wrong?